Tourmaline Bio Reports on Shareholder Vote Matters
| Field | Detail |
|---|---|
| Company | Tourmaline Bio, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Tourmaline Bio held a shareholder vote on June 4th. Details to follow.
AI Summary
Tourmaline Bio, Inc. filed an 8-K on June 6, 2025, reporting on matters submitted to a vote of security holders on June 4, 2025. The company, formerly known as Talaris Therapeutics, Inc., is incorporated in Delaware and headquartered in New York. This filing pertains to the submission of specific items for shareholder approval.
Why It Matters
This filing indicates that Tourmaline Bio held a shareholder vote, which could signal significant corporate actions or changes requiring shareholder consent.
Risk Assessment
Risk Level: low — This is a routine filing reporting on a shareholder vote, not indicating immediate financial distress or significant operational changes.
Key Numbers
- 001-40384 — SEC File Number (Identifies the company's filing with the SEC.)
- 83-2377352 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Tourmaline Bio, Inc. (company) — Registrant
- Talaris Therapeutics, Inc. (company) — Former company name
- June 4, 2025 (date) — Date of earliest event reported
- June 6, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Principal executive offices location
FAQ
What specific matters were submitted to a vote of Tourmaline Bio's security holders on June 4, 2025?
The filing states that matters were submitted to a vote of security holders on June 4, 2025, but the specific details of these matters are not provided in the excerpt.
When was Tourmaline Bio, Inc. formerly known as Talaris Therapeutics, Inc.?
The company was formerly known as Talaris Therapeutics, Inc., with a date of name change not specified in this excerpt but indicated by the former name field.
What is the principal executive office address for Tourmaline Bio, Inc.?
The principal executive offices are located at 27 West 24th Street, Suite 702, New York, NY 10010.
In which state is Tourmaline Bio, Inc. incorporated?
Tourmaline Bio, Inc. is incorporated in Delaware.
What is the SEC filing number for Tourmaline Bio, Inc.?
The SEC file number for Tourmaline Bio, Inc. is 001-40384.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Tourmaline Bio, Inc..